Clinical Trials: Gastrointestinal Diseases and Disorders

Arizona

Tucson; Advanced Clinical Therapeutics LLC
Act Now Research Studies for:

California

Duarte; City of Hope
PHII-66 NCI#7028: A Phase II Study of BAY 43-9006 for Patients with Imatinib-and Sunitinib Resistant Gastrointestinal Stromal Tumor

Encinitas; Discovery Clinical Research
Have you been diagnosed with Acute Diverticulitis and are experiencing flare up of symptoms including abdominal pain?

Massachusetts

Boston; Brigham and Women's Hospital (BWH)
Are you currently pregnant and have been diagnosed with Inflammatory Bowel Disease (IBD)?

Boston; Brigham and Women's Hospital
Rifaximin and Hepatic Encephalopathy

New York

Manhasset; Biomedical Research Alliance of New York
Colostomy- Ostomy bags

New York; Herbert Irving Cancer Center of Columbia University
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Of SU011248 In The Treatment Of Patients With Imatinib Mesylate (Gleevec™, Glivec®)-Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor.

New York; Columbia Presbyterian
A Phase I-II, Open Label Study of RAD001 in Combination with Glivec®/Gleevec™ (Imatinib) in Patients with Glivec/Gleevec-Refractory/Resistant Gastrointestinal Stromal Tumors


Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: May 14, 2008 at 3:22:04 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA